MOLECULAR DIAGNOSIS

Showing 1–100 of 154 results

Lung Cancer (FISH + NGS)

Retinal Degeneration Gene Panel

Colon Cancer (Fragment Analysis + NGS)

Glioma Panel (MLPA + FISH + Sanger Sequencing)

Renal Cancer Gene Panel

Replication Factor C1 Mutation Screening (RFC1 – 80G>A)

Respiratory Virus Panel-7

Prenatal Sickle Cell Mutation Screening

Prenatal Spinal Muscular Atrophy (SMN1 Gene: Exon 7 and 8 deletion mutation screening)

Prostate Cancer Gene Panel

Prenatal DMD mutation screening (26 exons)

Polycystic Kidney Disease Gene Panel

Prenatal Beta Thalassemia/HbE Mutation Screening

PGS (7-12) Embryo

PIK3CA Mutation Analysis (Exon 9 & 20)

PML/RARA Qualitative [bcr 1 & 3]

PGD HLA Typing (Single Embryo)

PGS (1-4) Embryo

PGS (5-6) Embryo

PGD (Single Embryo)

PGD (Single Embryo) with maternal DNA contamination check

PGD (Single gene Disorder)-Baseline

Paternity testing-Autosomal STR (Fragment Analysis)

PDGFR Mutation Screening (Exons 12, 14, 18)

PDGFR, cKIT(Gastrointestinal Stromal Tumors)

ONCOMINE SOLID TUMOR DNA PANEL

ONCOMINE SOLID TUMOR RNA FUSION PANEL

ONCOMINE MYELOID PANEL

ONCOMINE cfDNA LUNG CANCER PANEL

ONCOMINE COMPREHENSIVE ASSAY

ONCOMINE FOCUS PANEL

NPM1 Mutation Analysis (Exon 12 insertion)

NRAS Mutation Analysis (codons 12 & 13)

ONCOMINE BREAST cfDNA ASSAY

Neuronal Ceroid Lipofuscinosis Gene Panel

Non-invasive Prenatal testing-EVAA

Muscular Dystrophy Gene Panel

Myeloproliferative Leukemia Mutation Screening (MPL – S505N; W515L)

Nervous system Cancer Gene Panel

MPN – Molecular Panel ( 4 markers )

MPZ Full Length Gene Sequence Analysis (Charcot-Maria-Tooth Disease)

MLC1 Gene Mutation Analysis (Agrawal Mutation)

MLL t(4;11)(q21;q23) Qualitative

Microsatellite Instability (Lynch Syndrome/ Colorectal Cancer)

MGMT Methylation Assay

Microarray (60K) Blood

Microcephaly Gene Panel

Metabolic Disorder Gene Panel

Methylenetetrahydrofolate Reductase (MTHFR – 2 Variants C677T, A1298C)

Methylenetetrahydrofolate Reductase (MTHFR), FACTOR V (F5), FACTOR II (F2)

MECP2 Full Gene Mutation Analysis (RETT Syndrome)

Melanoma/Skin Tumors

Maturity-Onset Diabetes of the Young (MODY) Gene Panel

KRAS Mutation Screening (Codons 12 & 13)

Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel

Lung & Colon Cancer Gene Panel

Lysosomal Storage Disorder Gene Panel

Jak 2 Mutation Detection Panel (Exons 12-15)

JAK2 Gene, V617F Mutation Detection

Irnotecan Toxicity Assessment(UGT1A1 Genotyping)

Huntington Disease (HD mutation screening)

Inborn Error Of Metabolism (DBS)

Inborn Error Of Metabolism (Urine) by GCMS

Human Immunodeficiency Virus 1 (HIV- 1) Quantitative PCR

Human Inmmuno-defecincy Virus – 1 (HIV-1) Drug Resistance Genotype

Human Papilloma Virus (HPV High-Risk) PCR with Genotyping

HR-HLA A, B, C, DRB1, DQB1

HR-HLA A, B, DRB1

Human Immunodeficiency Virus 1 (HIV- 1) Qualitative PCR

HLA A, B, DRB1-Low resolution

HLA-B*57:01 Genotyping (for Abacavir Hypersensitivity)

HLA-DRB1*1501 Genotyping (Multiple Sclerosis)

HIV-1 Proviral DNA PCR

HLA A, B, C, DRB1, DQB1- Low resolution

HLA A, B, C, DRB1, DQB1 (Any One)-Low resolution

Hepatitis B Virus (HBV) Genotype

Hepatitis C Virus (HCV) Genotype

Hereditary Spastic Paraplegia Gene Panel

Herpes Simplex Virus Type 1 & Type 2 (HSV 1 & 2) Qualitative PCR

Hemochromatosis Common Mutation Analaysis in HFE Gene (H63D, S61C & C282Y)

Hemochromatosis HFE Full Gene Sequence Analysis

Hemophilia A Common Mutation Screening (Factor VIII Intron 22 and Intron 1 Inversion analysis)

Haemophilia A & B gene Panel

HBB Full Gene Analysis (?-Thallassemia)

HbE (Hemoglobin E) mutation screening

Glucose-6-Phosphate Dehydrogenase (G6PD) full length gene sequence analysis

Glycogen Storage Disorder Gene Panel

Gynaecological cancer Gene Panel

Gastro-Intestinal Cancer Gene Panel

GATA2 Full length gene sequencing (Chronic Neutropenia, MonoMac Syndrome, Mylodysplasia, AML)

Gilbert Syndrome (UGT1A1 Genotyping)

Familial Mediterranean Fever: MEFV full gene Analysis

FLT3 (ITD, D835Y) MUTATION

FLT3/ITD Allelic Ratio

Fragile X Syndrome (FMR1)

Endocrine Cancer Gene Panel

Epidermal Growth Factor Receptor Mutation Analysis (EGFR – Exon 18, 19, 20, 21)

FACTOR II Mutation Screening (F2 – G20210A)

FACTOR V Leiden Mutation Screening (F5 – G1691A)

E2A t(1;19)(q23;p13) Qualitative PCR